VC Catalog · venture ecosystem research library
VC Catalog home Beta

VC firm

Mountain State Capital

Kingmaker TierBased on the data VC Catalog holds.

Kingmaker Tier: 83 out of 100

  • AI models & AI infrastructure
  • Biotech & therapeutics
  • Care delivery & digital health
  • Cloud & networking
  • Cybersecurity
  • Data & analytics
  • Developer tools
  • Health IT
  • HR & future of work
  • Legal, compliance & govtech
  • Medical devices & diagnostics
  • Mental health & wellness
  • Productivity & collaboration
  • Sales & marketing tech
  • Vertical software
  • Women's & family health
  • Seed
  • US
  • VC
  • B2B
Investor type
VC
Investing status
Activeas of 2026-09-18Source (opens in a new tab)
Headquarters
United States
Check size
we will typically invest between $200,000 - $500,000Source (opens in a new tab)
Claim, correct or request removal

Record updated 18 September 2026

Investment approach

Thesis
We invest when a company has found its product-market fit and is ready to scale. Software, hardware and services companies should have deployed a version of their solution to early adopters and should be able to demonstrate an understanding of their sales process and the market’s willingness to pay. Life sciences companies should have generated data that validate the efficacy of their solution, and should understand their development costs, regulatory pathway and potential partners.Source (opens in a new tab)
Reserves policy
In most cases, we expect that the company will require additional investment in the coming years, and we therefore reserve sufficient capital to participate in the follow-on rounds of our best-performing portfolio companies.
Eligibility
We meet and communicate frequently with our portfolio companies, and prefer to invest within a 6-hour driving distance from our offices in Pittsburgh, PA and Morgantown, WV.
Traction requirement
We invest when a company has found its product-market fit and is ready to scale. Software, hardware and services companies should have deployed a version of their solution to early adopters and should be able to demonstrate an understanding of their sales process and the market’s willingness to pay. Life sciences companies should have generated data that validate the efficacy of their solution, and should understand their development costs, regulatory pathway and potential partners.
Investing status notes
We invest when a company has found its product-market fit and is ready to scale.

Locations

Office
Morgantown, WV, United States
Office
Pittsburgh, PA, United States
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy